• Join
  • Login
  • Contact

Search abstracts / presentations

Analysis of cisplatin incorporation intohuman breast adenocarcinoma mcf-7 cells by quantitative polymerase chain reaction

  • In: SIG Pharmaceutical Biotechnology Posters
  • At: New Orleans (USA) (2004)
  • Type: Poster
  • Poster code: PB-P010
  • By: RATANAPHAN, Adisorn (Prince of Songkla University, Pharmaceutical Chemistry, Hat-yai, Songkla, Thailand)
  • Co-author(s): Wasiksiri, Siriwat (Prince of Songkla University, HAT-YAI, SONGKLA, Thailand)
    Canyuk, Bhutorn (Prince of Songkla University, HAT-YAI, SONGKLA, Thailand)
  • Abstract:

    Cisplatin is an anticancer drug for the treatment of cancers affecting various organs including ovary and testes. Cisplatin essentially exerts its cytotoxicity against cencerous cells via covalent attachment of platinum atom to DNA, generating various platinated DNA adducts. Development of second cancer in patients previously treated with..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses